Susan Klapholz

Title: The Innovations of Susan Klapholz

Introduction

Susan Klapholz is a notable inventor based in Stanford, CA. She has made significant contributions to the field of biotechnology, particularly in the development of transgenic non-human animals. With a total of 2 patents, her work focuses on enhancing the specificity and diversity of human antibodies.

Latest Patents

Susan Klapholz's latest patents involve transgenic non-human animals engineered to contain human immunoglobulin gene loci. These animals possess human Ig loci that include plural variable (V and Vκ) gene regions. The inclusion of these plural variable region genes enhances the specificity and diversity of human antibodies produced by the animals. Furthermore, this innovation reconstitutes B-cell development, resulting in animals that possess abundant mature B-cells secreting extremely high affinity antibodies.

Career Highlights

Throughout her career, Susan has worked with prominent companies in the biotechnology sector, including Amgen Fremont Inc. and Abgenix, Inc. Her expertise in the field has led to groundbreaking advancements in antibody production and therapeutic applications.

Collaborations

Some of her notable coworkers include Larry L Green and Aya Jakobovits, who have also contributed to the advancements in biotechnology and immunology.

Conclusion

Susan Klapholz's innovative work in transgenic technology has paved the way for significant advancements in the production of human antibodies. Her contributions continue to impact the field of biotechnology and improve therapeutic options for various diseases.